Blinatumomab is an injectable drug that functions as an antibody, binding to the membranes of cancer cells and allowing them to be more easily identified by the immune system. In this way, defense cells have a greater ability to eliminate cancer cells, especially in the case of acute lymphoblastic leukemia.
This medicine may also be known commercially as Blincyto and should only be used in the hospital for cancer treatment under the guidance of an oncologist.
Price
This medicine can not be bought in conventional pharmacies and is only used during the treatment of cancer in the hospital or in specialized centers, such as INCA, for example.
What is it for
Blinatumomab is indicated for the treatment of precursor B-cell acute lymphoblastic leukemia, Philadelphia chromosome-negative, relapsed or refractory.
How to use
The dose of blinatumomab to be administered should always be directed by an oncologist, as it varies according to the characteristics of the person and the stage of evolution of the disease.
Treatment is done with 2 cycles of 4 weeks each, separated by 2 weeks, and must be hospitalized during the first 9 days of the first cycle and for 2 days of the second cycle.
Possible side effects
The most common side effects of using this remedy include anemia, excessive tiredness, low blood pressure, insomnia, headache, tremors, dizziness, cough, nausea, vomiting, constipation, abdominal pain, back pain, fever, pain in the joints, chills and changes in blood test.
Who should not use
Blinatumomab is contraindicated for women who are breast-feeding and people who are allergic to any of the ingredients in the formula. In addition, in the case of pregnant women, it should only be used with guidance from the obstetrician.
